Merck KGaA (OTCMKTS:MKGAF) Hits New 52-Week Low – Here’s What Happened

Merck KGaA (OTCMKTS:MKGAF)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $142.05 and last traded at $142.05, with a volume of 228 shares changing hands. The stock had previously closed at $145.80.

Analyst Ratings Changes

Separately, The Goldman Sachs Group raised Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Stock Performance

The stock’s 50 day moving average is $156.52 and its two-hundred day moving average is $170.68. The firm has a market capitalization of $18.52 billion, a P/E ratio of 21.88 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.